our efforts were directed towards the synthesis of new heterocyclic compounds containing quinoline ring bearing pyrazole and pyridine moieties with anticipated biological activities.
Introduction
Quinoline derivatives have attracted considerable interest for many years due to their chemical reactivity and biological activity [1] [2] [3] [4] . Literature surveys revealed that these derivatives possesses anti-inflammatory [5, 6] antimicrobial [7, 8] , antimalarial [9, 10] , antioxidant [11, 12] , antitumor [13, 14] , antiprotozoal [15] , antituberculosis [16, 17] and antiulcer activity [18] , as well as, A3 adenosine receptor antagonists [19] . On the other hand, pyrazole derivatives are known to exhibit diverse biological activities including anti-inflammatory [20] , anticancer [21] and antimicrobial [22, 23] activity. Also, many pyridine dicarbonitrile derivatives were reported to have significant biological activity such as anti-inflammatory and analgesic activities [24] . In the light of these mentioned facts and our interest in designing new biologically active molecules,
Preparation of 2-hydrazinylquinoline 1
2-Chloroquinoline (1.0 g, 6.1 mmol) and hydrazine monohydrate (3 mL) in n-butanol (10 mL) were refluxed for 6 h. The solvent was removed under reduced pressure giving a brownish orange residue, the residue was triturated with ethanol then filtered to give compound 1, orange crystals, yield 86.5 %; mp 140-142 °C; IR (KBr, cm -1 ): 3282, 3188 (NH), 3042 (CH arom ), 1621(C=N).
General procedure for the synthesis of (E)-2-(2-(1-(4-substituted)ethylidene)hydrazineyl) quinoline derivatives 2a-c
A mixture of compound 1 (1.0 g, 6.3 mmol) and substituted acetophenone (6.3 mmol), was refluxed in ethanol (20 mL) containing (1 mL) of hydrochloric acid for 6 h. The solvent was reduced to its half, and allowed to cool. The separated solid was filtered, dried, and recrystallized from ethanol. 
3-(4-Chlorophenyl)-1-(quinolin-2-yl)-1H-pyrazole-4-carbaldehyde 3c
Yellow 
General procedure for the synthesis of 2-amino-4-(3-(4-aryl)-1-(quinolin-2-yl)-1H-pyrazol-4-yl)-6-(alkylthio)pyridine-3,5-dicarbonitrile 11a-f
Aldehyde derivatives 3a-c (1 mmol), malononitrile (2 mmol), thiophenol or mercapto ethanol (1 mmol) and few drops of piperidine were mixed in ethanol and refluxed for 1 h. to the completion of reaction (monitored by TLC). The reaction mixture was cooled and precipitate formed was filtered and recrystallized from ethanol to yield the pure product.
2-Amino-4-(3-phenyl-1-(quinolin-2-yl)-1H-pyrazol-4-yl)-6-(phenylthio)pyridine-3,5-dicarbonitrile 11a
Yellow solid; yield 76 %; mp 160-162 °C; 
2-Amino-6-(phenylthio)-4-(1-(quinolin-2-yl)-3-(p-tolyl)-1H-pyrazol-4-yl)pyridine-3,5-dicarbonitrile 11c
2-Amino-6-(ethylthio)-4-(1-(quinolin-2-yl)-3-(p-tolyl)-1H-pyrazol-4-yl)pyridine-3,5-dicarbonitrile 11d
Yellow Amino-4-(3-(4-chlorophenyl)-1-(quinolin-2-yl)-1H-pyrazol-4-yl)-6-(ethylthio)pyridine-3 
2-Amino-4-(3-(4-chlorophenyl)-1-(quinolin-2-yl)-1H-pyrazol-4-yl)-6-(phenylthio)pyridine

2-
Antimicrobial activity
The new compounds were evaluated for their antibacterial activities against two Gram positive bacteria (Staphelococcus aureus ATCC 6538 and B. subtilis ATCC6633), two Gram negative bacteria (Salmonellatyphimurium ATCC14028 and E. coli ATCC 8739) at a concentration 100 µg/ml. Also, the derivatives were tested for their antifungal activities against (Candida albicans ATCC10231). Dimethylsulfoxide was used as a solvent for tested compounds and was used as a negative control. Ciprofloxacin and Ketoconazole at concentration of 100 µg/mL in dimethylsulfoxide were used as positive control. After incubation period, the growth inhibition zones diameters were carefully measured in mm.
Results and Discussion
Synthesis of target compounds (11a-f) was achieved as outlined in (Schemes 1 and 3) . The starting material 2-hydrazinylquinoline 1 was synthesized in a high yield from the reaction of hydrazine hydrate with 2-chloroquinoline in refluxing n-butanol, through procedures similar to the previously reported method [25] and its modification [26] . Structure of compound 1 was confirmed by its IR spectrum that revealed presence of two bands at 3282, 3188 cm -1 corresponding to NH groups and two bands at 3042, 1621 cm Formation of compounds 3a-c was supported by their IR spectra that showed peaks at 2920-2823 and 1648-1680 cm -1 corresponding to CH and C=O stretching respectively and there was no absorption bands at the NH region. Also, their 1 H NMR spectra showed two sharp singlet signals at δ 10.11 ppm due to aldehydic proton of -CHO group and at δ 9.6 ppm due to =C-H of the pyrazole ring. On the other hand, the molecular ion peaks shown in the Mass spectra of all derivatives were in agreement with their molecular formula.
Derivatives 3a-c in turn react in one-pot with malononitrile and thiophenol or ethyl mercaptan in absolute ethanol added to it a few drops of piperidine to give 2-amino-4-(3-(4-aryl)-1-(quinolin-2-yl)-1H-pyrazol-4-yl)-6-(alkylthio) pyridine-3,5-dicarbonitrile derivatives 11a-f (Scheme 3).
The mechanism of this reaction has been discussed in accordance with the mechanism suggested in literature [28] , the first step of this process involves the Knoevenagel condensation of formylpyrazole derivative with malononitrile to form the corresponding 2-(1,3-substitutedlH-pyrazol-4-yl)methylene)malononitrile 9; The second molecule of malononitrile then undergoes Michael addition to compound 9 followed by simultaneous thiolate addition to -C≡N of the adduct and cyclization to dihydropyridine 10 which on aromatization and oxidation under the reaction conditions leads to pyridine derivatives 11a-f. 
Structures of compounds 11a-f
were supported by their elemental analysis and spectral data too. Mass spectrometry of all derivatives showed the molecular ion peaks close to their expected values. Also, 1 H NMR spectra showed characteristic singlet signals at δ 9.23 due to =C-H of the pyrazole ring, besides other singlet signals at δ 4.36 ppm which was assigned to NH 2 group. IR spectra of compounds 11a-f have characteristic peaks at 3421-3396, 3216-3178 cm -1 due to -NH 2 groups, and peaks at 2360-2159 cm -1 due to -C≡N groups which in turn confirm the structure of target compounds.
Antimicrobial activity
New compounds were screened in vitro for their antibacterial activities against two Gram positive bacteria (Staphelococcus aureus ATCC 6538 and B. subtilis ATCC6633), two Gram negative bacteria (Salmonellatyphimurium ATCC14028 and E. coli ATCC 8739) at a concentration 100 µg/ml. Also, the derivatives were tested for their antifungal activities against (Candida albicans ATCC10231). Dimethylsulfoxide was used as a solvent for tested compounds and was used as a negative control showing no activity against tested microorganisms. Ciprofloxacin and Ketoconazole at concentration of 100 µg/mL in dimethylsulfoxide were used as positive control. Antimicrobial tests were carried out by the agar diffusion technique [29] . Table 1 summarizes the results of antimicrobial studies, in which compounds 3a-c and 11a-f exhibited excellent activity against Candida albicans compared to ketoconazole drug. On the other, hand compounds 3c and 11a-f possesses considerably broader antimicrobial activity compared to Ciprofloxacin. Rest of derivatives showed good to moderate activity against the tested microorganisms.
Conclusion
Nine derivatives were synthesized and in vitro evaluated for antibacterial activity against five pathogenic microorganisms. In conclusion these compounds possess a broad spectrum of activity against a group of bacteria, responsible for causing most common bacterial diseases. This paper opens the possibility of finding new effective bactericidal compounds.
